Skip to main content
Top
Published in: Neurocritical Care 1/2008

01-08-2008 | Original Article

The Coagulopathy of Acute Liver Failure and Implications for Intracranial Pressure Monitoring

Authors: Santiago J. Munoz, K. Rajender Reddy, William Lee, The Acute Liver Failure Study Group

Published in: Neurocritical Care | Issue 1/2008

Login to get access

Abstract

Introduction

The development of coagulopathy in acute liver failure (ALF) is universal. The severity of the coagulopathy is often assessed by determination of the prothrombin time and International Normalized Ratio (INR).

Discussion

In more than 1,000 ALF cases, the severity of the coagulopathy was moderate in 81% (INR 1.5–5.0), severe in 14% (INR 5.0–10.0), and very severe in 5% (INR > 10.0). Certain etiologies were associated with more severe coagulopathy, whereas ALF caused by fatty liver of pregnancy had the least severe coagulopathy.

Methods

Management consisted of transfusions of FFP in 92%. Overall, FFP administered during the first week of admission amounted to 13.7 ± 15 units.

Results

Patients who received an ICP monitor had significantly more FFP transfused than those managed without ICP monitor (22.7 ± 2.4 vs. 12.3 ± 0.8 units FFP; P < 0.001). Only a minority of patients developed gastrointestinal bleeding or had an intracranial pressure monitor installed.

Conclusion

Further research is necessary to explore the reasons clinicians transfuse ALF patients with large amounts of FFP in the absence of active bleeding or invasive procedures.
Literature
1.
go back to reference Schiodt F, Atillasoy E, Shakil O, Schiff E, Caldwell C, Kowdley K, et al. Etiology and outcome for 295 patients with acute liver failure in the United States. Liver Transpl. 1999;5:29–34.CrossRef Schiodt F, Atillasoy E, Shakil O, Schiff E, Caldwell C, Kowdley K, et al. Etiology and outcome for 295 patients with acute liver failure in the United States. Liver Transpl. 1999;5:29–34.CrossRef
2.
go back to reference Ostapowicz G, Fontana R, Schiodt F, Larson A, Davern T, Han S, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Int Med. 2002;137:947–54.PubMed Ostapowicz G, Fontana R, Schiodt F, Larson A, Davern T, Han S, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Int Med. 2002;137:947–54.PubMed
3.
go back to reference Clark R, Rake MO, Flute PT, Williams R. Coagulation abnormalities in acute liver failure; pathogenetic and therapeutic implications. Scand J Gastroent (Suppl). 1973;19:63–70. Clark R, Rake MO, Flute PT, Williams R. Coagulation abnormalities in acute liver failure; pathogenetic and therapeutic implications. Scand J Gastroent (Suppl). 1973;19:63–70.
4.
go back to reference Pereira SP, Langley PG, Williams R. The management of abnormalities of hemostasis in acute liver failure. Sem Liver Dis. 1996;16:403–14. Pereira SP, Langley PG, Williams R. The management of abnormalities of hemostasis in acute liver failure. Sem Liver Dis. 1996;16:403–14.
5.
go back to reference Trotter JF. Coagulation abnormalities in patients who have liver disease. Clin Liver Dis. 2006;10:665–78.PubMedCrossRef Trotter JF. Coagulation abnormalities in patients who have liver disease. Clin Liver Dis. 2006;10:665–78.PubMedCrossRef
6.
go back to reference Lisman T, Leebeek F. Hemostatic alterations in liver disease: a review on pathophysiology, clinical consequences, and treatment. Dig Surg. 2007;24:250–8.PubMedCrossRef Lisman T, Leebeek F. Hemostatic alterations in liver disease: a review on pathophysiology, clinical consequences, and treatment. Dig Surg. 2007;24:250–8.PubMedCrossRef
7.
go back to reference O’Grady JG, Langley PG, Sisola L, Aladort L, Williams R. Coagulopathy of fulminant hepatic failure. Sem Liver Dis. 1986;6:159–63. O’Grady JG, Langley PG, Sisola L, Aladort L, Williams R. Coagulopathy of fulminant hepatic failure. Sem Liver Dis. 1986;6:159–63.
8.
go back to reference Lisman T, Leebeek FWG, de Groot P. Haemostatic abnormalities in patients with liver disease. J Hepatol. 2002;37:280–7.PubMedCrossRef Lisman T, Leebeek FWG, de Groot P. Haemostatic abnormalities in patients with liver disease. J Hepatol. 2002;37:280–7.PubMedCrossRef
9.
go back to reference Caldwell SH, Hoffman M, Lisman T, Macik B, Northup P, Reddy K, et al. Coagulation disorders and hemostasis in liver disease: physiopathology and critical assessment of current management. Hepatology. 2006;44:1039–46.PubMedCrossRef Caldwell SH, Hoffman M, Lisman T, Macik B, Northup P, Reddy K, et al. Coagulation disorders and hemostasis in liver disease: physiopathology and critical assessment of current management. Hepatology. 2006;44:1039–46.PubMedCrossRef
10.
go back to reference Stravitz RT, Kramer AH, Davern T, Shaikh O, Caldwell S, Mehta R, et al. Intensive care of patients with acute liver failure: recommendations of the U.S. Acute Liver Failure Study Group. Crit Care Med. 2007;35:2498–508.PubMed Stravitz RT, Kramer AH, Davern T, Shaikh O, Caldwell S, Mehta R, et al. Intensive care of patients with acute liver failure: recommendations of the U.S. Acute Liver Failure Study Group. Crit Care Med. 2007;35:2498–508.PubMed
11.
go back to reference Gazzard BG, Henderson JM, Williams R. Early changes in coagulation following a paracetamol overdose and a controlled trial of fresh frozen plasma therapy. Gut. 1975;16:617–20.PubMedCrossRef Gazzard BG, Henderson JM, Williams R. Early changes in coagulation following a paracetamol overdose and a controlled trial of fresh frozen plasma therapy. Gut. 1975;16:617–20.PubMedCrossRef
12.
13.
go back to reference Trey C, Davidson C. The management of fulminant hepatic failure. Prog Liver Dis. 1970;3:282–98.PubMed Trey C, Davidson C. The management of fulminant hepatic failure. Prog Liver Dis. 1970;3:282–98.PubMed
14.
go back to reference Munoz S. Prothrombin time in fulminant hepatic failure. Gastroenterology. 1991;100:1480–9.PubMed Munoz S. Prothrombin time in fulminant hepatic failure. Gastroenterology. 1991;100:1480–9.PubMed
15.
go back to reference Tripodi A, Salerno F, Chantarangkul V, Clerici M, Cazzaniga M, Primignani M, et al. Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests. Hepatology. 2005: 41:553–8.PubMedCrossRef Tripodi A, Salerno F, Chantarangkul V, Clerici M, Cazzaniga M, Primignani M, et al. Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests. Hepatology. 2005: 41:553–8.PubMedCrossRef
16.
go back to reference Reverter JC. Abnormal hemostasis tests and bleeding in chronic liver disease: are they related? Yes. J Thromb Haemostasis. 2006;4:717–20.CrossRef Reverter JC. Abnormal hemostasis tests and bleeding in chronic liver disease: are they related? Yes. J Thromb Haemostasis. 2006;4:717–20.CrossRef
17.
go back to reference Robert A, Chazouilleres O. Prothrombin time in liver failure: time, ratio, activity percentage, or international normalized ratio? Hepatology. 1996;24:1392–4.PubMedCrossRef Robert A, Chazouilleres O. Prothrombin time in liver failure: time, ratio, activity percentage, or international normalized ratio? Hepatology. 1996;24:1392–4.PubMedCrossRef
18.
go back to reference MacDougall BR, Bailey RJ, Williams R. H2-receptor antagonists and antacids in the prevention of acute gastrointestinal haemorrhage in fulminant hepatic failure. Two controlled trials. Lancet. 1977;1:617–9.PubMedCrossRef MacDougall BR, Bailey RJ, Williams R. H2-receptor antagonists and antacids in the prevention of acute gastrointestinal haemorrhage in fulminant hepatic failure. Two controlled trials. Lancet. 1977;1:617–9.PubMedCrossRef
19.
go back to reference Blei AT, Olafsson S, Webster S, Levy R. Complications of intracranial pressure monitoring in fulminant hepatic failure. Lancet. 1993;341:157–8.PubMedCrossRef Blei AT, Olafsson S, Webster S, Levy R. Complications of intracranial pressure monitoring in fulminant hepatic failure. Lancet. 1993;341:157–8.PubMedCrossRef
20.
go back to reference Vaquero J, Fontana RJ, Larson A, Bass N, Davern T, Shakil O, et al. Complications and use of intracranial pressure monitoring in patients with acute liver failure and severe encephalopathy. Liver Transpl. 2005;11:1581–9.PubMedCrossRef Vaquero J, Fontana RJ, Larson A, Bass N, Davern T, Shakil O, et al. Complications and use of intracranial pressure monitoring in patients with acute liver failure and severe encephalopathy. Liver Transpl. 2005;11:1581–9.PubMedCrossRef
21.
go back to reference Donaldson BW, Gopinath R, Wanless I, Phillips M, Cameron R, Roberts E, et al. The role of transjugular liver biopsy in fulminant liver failure: relation to other prognostic indicators. Hepatology. 1993;18:1370–6.PubMed Donaldson BW, Gopinath R, Wanless I, Phillips M, Cameron R, Roberts E, et al. The role of transjugular liver biopsy in fulminant liver failure: relation to other prognostic indicators. Hepatology. 1993;18:1370–6.PubMed
22.
go back to reference Mor E, Jennings L, Gonwa TA, Holman M, Gibbs J, Solomon H, et al. The impact of operative bleeding on outcome in transplantation of the liver. Surg Gyn Obst. 1993;176:219–27.PubMed Mor E, Jennings L, Gonwa TA, Holman M, Gibbs J, Solomon H, et al. The impact of operative bleeding on outcome in transplantation of the liver. Surg Gyn Obst. 1993;176:219–27.PubMed
23.
go back to reference O’Grady JG, Alexander GJ, Thick M, Potter D, Calne R, Williams R. Outcome of orthotopic liver transplantation in the aetiological and clinical variants of acute liver failure. Q J Med. 1988;68:817–24.PubMed O’Grady JG, Alexander GJ, Thick M, Potter D, Calne R, Williams R. Outcome of orthotopic liver transplantation in the aetiological and clinical variants of acute liver failure. Q J Med. 1988;68:817–24.PubMed
24.
go back to reference Bernal W, Wendon J, Rela M, Heaton N, Williams R. Use and outcome of liver transplantation in acetaminophen-induced acute liver failure. Hepatology. 1998;27:1050–5.PubMedCrossRef Bernal W, Wendon J, Rela M, Heaton N, Williams R. Use and outcome of liver transplantation in acetaminophen-induced acute liver failure. Hepatology. 1998;27:1050–5.PubMedCrossRef
25.
go back to reference Devlin J, Wendon J, Heaton N, Tan K, Williams R. Pretransplantation clinical status and outcome of emergency transplantation for acute liver failure. Hepatolog Wily. 1995;21:1018–24.PubMedCrossRef Devlin J, Wendon J, Heaton N, Tan K, Williams R. Pretransplantation clinical status and outcome of emergency transplantation for acute liver failure. Hepatolog Wily. 1995;21:1018–24.PubMedCrossRef
26.
go back to reference Farmer DG, Anselmo DM, Ghobrial RM, Yersiz H, McDiarmid S, Cao C, et al. Liver transplantation for fulminant hepatic failure: experience with more than 200 patients over a 17-year period. Ann Surg. 2003;237:666–75.PubMedCrossRef Farmer DG, Anselmo DM, Ghobrial RM, Yersiz H, McDiarmid S, Cao C, et al. Liver transplantation for fulminant hepatic failure: experience with more than 200 patients over a 17-year period. Ann Surg. 2003;237:666–75.PubMedCrossRef
27.
go back to reference Muñoz S. Difficult management problems in fulminant hepatic failure. Sem Liver Dis. 1993;13:395–413. Muñoz S. Difficult management problems in fulminant hepatic failure. Sem Liver Dis. 1993;13:395–413.
28.
go back to reference Munoz S, Stravitz R, Gabriel D. Coagulopathy of acute liver failure. Clin Liver Dis. 2008; in press. Munoz S, Stravitz R, Gabriel D. Coagulopathy of acute liver failure. Clin Liver Dis. 2008; in press.
29.
go back to reference Shami V, Caldwell S, Hespenheide E. Recombinant activated factor VII for the coagulopathy of fulminant hepatic failure compared with conventional therapy. Liver Transpl. 2003;9:138–43.CrossRef Shami V, Caldwell S, Hespenheide E. Recombinant activated factor VII for the coagulopathy of fulminant hepatic failure compared with conventional therapy. Liver Transpl. 2003;9:138–43.CrossRef
30.
go back to reference Quan D, Bass N, Hirose R. The effect of recombinant factor VIIa and fresh frozen plasma on the INR in patients with acute and chronic liver failure. Hepatology. 2003;38(4):550A.CrossRef Quan D, Bass N, Hirose R. The effect of recombinant factor VIIa and fresh frozen plasma on the INR in patients with acute and chronic liver failure. Hepatology. 2003;38(4):550A.CrossRef
31.
go back to reference Porte R, Caldwell S. The role of recombinant factor VIIa in liver transplantation. Liver Transpl. 2005;11:872–4.CrossRef Porte R, Caldwell S. The role of recombinant factor VIIa in liver transplantation. Liver Transpl. 2005;11:872–4.CrossRef
Metadata
Title
The Coagulopathy of Acute Liver Failure and Implications for Intracranial Pressure Monitoring
Authors
Santiago J. Munoz
K. Rajender Reddy
William Lee
The Acute Liver Failure Study Group
Publication date
01-08-2008
Publisher
Humana Press Inc
Published in
Neurocritical Care / Issue 1/2008
Print ISSN: 1541-6933
Electronic ISSN: 1556-0961
DOI
https://doi.org/10.1007/s12028-008-9087-6

Other articles of this Issue 1/2008

Neurocritical Care 1/2008 Go to the issue